MedTrace Logo

AirWaze - Easy and Advanced Tools for CBCT Guided Lung Interventions

NCT06046001 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2026-04-16

Study results available
· View outcomes & findings →

Summary

The goal of this clinical trial is to assess the overall usability of the Philips

AirWaze investigational device in patients indicated for CBCT-guided navigation bronchoscopy procedure. The main questions it aims to answer are to assess the:

* overall usability of the device
* accuracy of the tool-in-lesion confirmation scan

Participants will undergo bronchoscopy with the new navigation device and additional confirmation scans. Follow-up visit at 7days will be performed.

Conditions

  • Lung Diseases

Interventions

DEVICE

AirWaze

AirWaze - easy and advanced tools for CBCT guided lung interventions

Sponsors & Collaborators

  • Philips Clinical & Medical Affairs Global

    lead INDUSTRY

Principal Investigators

  • Erik van der Heijden · Radboudumc Nijmegen, Netherlands

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-27
Primary Completion
2024-12-20
Completion
2025-01-03

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06046001 on ClinicalTrials.gov